Clinical trial
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
NCT06111781
Study timeline
Study start (actual)2024-04-15Date precision: day
Registry last updated2026-09-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancerunresolved
Interventions
Relugolix 120 MG [Orgovyx]DRUG · verified · RxNorm: relugolix 120 MG [Orgovyx]
Sponsors & collaborators
Yale Universitylead sponsor
Pfizercollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06111781 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.